Skip to main content

Table 1 Demographic and clinical characteristics of the patients with sepsis following ICU admission

From: Development and validation of a score to predict mortality in ICU patients with sepsis: a multicenter retrospective study

Variables

Midwest development cohort

(n = 4236); n (%)

West validation cohort

(n = 3185)

South validation cohort

(n = 3333)

Wenzhou validation cohort

(n = 1878)

n (%)

P value*

n (%)

P value*

n (%)

P value*

Demographics and social history

       

 Age, median (IQR, years)

69 (57, 80)

68 (56, 79)

0.027

69 (58, 80)

0.939

69 (57.25, 80)

0.949

 Male sex, n (%)

2252 (53)

1650 (52)

0.26

1716 (52)

0.164

1020 (54)

0.422

 Race, n (%)

  

 < 0.001

 

 < 0.001

  

 African American

411 (10)

107 (3)

 

629 (19)

   

 Asian

53 (1)

82 (3)

 

44 (1)

   

 Caucasian

3426 (81)

2495 (78)

 

2277 (68)

   

 Hispanic

54 (1)

183 (6)

 

219 (7)

   

 Native American

23 (1)

79 (2)

 

13 (0)

   

 Other/unknown

269 (6)

239 (8)

 

151 (5)

   

 Height, median (IQR, cm)

170 (161.8, 177.8)

170 (162, 177.8)

0.481

167.6 (160, 177.8)

0.035

170 (160, 177.8)

0.796

 Weight, median (IQR)

77.1 (63.5, 95)

77.6 (64.4, 96.5)

0.244

77 (63.5, 94.2)

0.697

76.9 (63.4, 93.5)

0.207

 Infection site, n (%)

  

0.014

 

 < 0.001

 

 < 0.001

 Pulmonary

1745 (41)

1212 (38)

 

929 (28)

 

725 (39)

 

 Renal/UTI

985 (23)

770 (24)

 

862 (26)

 

389 (21)

 

 Cutaneous/soft tissue

337 (8)

280 (9)

 

231 (7)

 

140 (7)

 

 GI

544 (13)

468 (15)

 

384 (12)

 

250 (13)

 

 Gynecologic

9 (0)

14 (0)

 

12 (0)

 

2 (0)

 

 Other

173 (4)

111 (3)

 

420 (13)

 

137 (7)

 

 Unknown

443 (10)

330 (10)

 

495 (15)

 

235 (13)

 

 Ventilation, n (%)

1411 (33)

1142 (36)

0.024

1110 (33)

1

643 (34)

0.497

Severity score

       

 SOFA, median (IQR)

5 (3, 7)

5 (3, 7)

 < 0.001

5 (3, 7)

0.004

5 (3, 7)

0.001

 APACHE IV, median (IQR, Kg)

67 (53, 84)

71 (56, 90)

 < 0.001

71 (57, 89)

 < 0.001

71 (55, 90.75)

 < 0.001

Vital signs

       

 Temperature, median (IQR)

37.4 (36.9, 38.1)

37.3 (36.9, 38.1)

0.787

37.3 (36.9, 38.1)

0.140

37.4 (36.9, 38.1)

0.673

 Heart rate, median (IQR)

109 (94, 125)

112 (97, 128)

 < 0.001

110 (96, 126)

0.020

111 (96, 127)

0.004

 Respiratory rate, median (IQR)

29 (24, 35)

29 (25, 35)

0.004

29 (24, 35)

0.011

29 (24, 35)

0.036

 Systolic pressure, median (IQR)

85 (75, 96)

84 (73, 95)

 < 0.001

83 (72, 95)

 < 0.001

84 (74, 96)

0.012

 Diastolic pressure, median (IQR)

45 (37, 52)

44 (36, 52)

0.018

44 (36, 51)

0.006

44 (36, 52)

0.093

 MAP, median (IQR, mmHg)

60 (52, 68)

59 (51, 67)

0.003

59 (51, 66)

 < 0.001

59 (51, 67)

0.059

 SpO2, median (IQR)

92 (89, 95)

92 (87, 95)

 < 0.001

92 (88, 95)

0.112

92 (88, 95)

0.195

Laboratory tests

       

 Albumin, median (IQR)

2.6 (2.1, 3)

2.5 (2.1, 3)

0.008

2.5 (2.1, 3)

0.039

2.5 (2.1, 3)

0.028

 Bicarbonate, median (IQR)

21 (17, 24)

20 (17, 24)

 < 0.001

20 (17, 24)

 < 0.001

20 (16.1, 23)

 < 0.001

 Bilirubin, median (IQR)

0.8 (0.5, 1.4)

0.8 (0.5, 1.5)

0.060

0.8 (0.5, 1.4)

0.658

0.8 (0.5, 1.4)

0.442

 Creatinine, median (IQR)

1.67 (1.1, 2.81)

1.73 (1.11, 2.91)

0.143

1.7 (1.1, 2.83)

0.438

1.77 (1.11, 2.95)

0.114

 Glucose, median (IQR)

107 (89, 136)

108 (88, 137)

0.771

108 (88, 136)

0.523

107 (88, 135)

0.283

 Hematocrit, median (IQR)

31 (26.4, 35.5)

30.7 (26.1, 35.2)

0.051

30.8 (26, 35.4)

0.070

30.5 (26.6, 35.48)

0.381

 Hemoglobin, median (IQR)

10.1 (8.6, 11.7)

10 (8.4, 11.6)

0.038

10 (8.4, 11.6)

0.033

10 (8.6, 11.7)

0.509

 Lactate, median (IQR)

2.4 (1.5, 4.2)

2.6 (1.6, 4.6)

 < 0.001

2.6 (1.6, 4.4)

 < 0.001

2.7 (1.6, 4.68)

 < 0.001

 Platelet, median (IQR)

157 (106, 226)

157 (105, 222)

0.489

160 (102, 224)

0.419

155 (105, 231)

0.915

 BUN, median (IQR)

33 (21, 52)

34 (22, 53)

0.122

34 (22, 53)

0.054

35 (22, 56)

0.002

 WBC, median (IQR)

15.62 (10.4, 21.91)

15.8 (10.7, 22.5)

0.121

16 (10.6, 22.8)

0.063

15.8 (10.9, 22.3)

0.103

 ALT, median (IQR)

28 (18, 56)

30 (18, 60)

0.141

30 (18, 59)

0.072

30 (18, 58)

0.165

Morbidities

       

 Dialysis, n (%)

205 (5)

168 (5)

0.426

170 (5)

0.641

91 (5)

1

 AIDS, n (%)

10 (0)

17 (1)

0.059

9 (0)

0.951

2 (0)

0.365

 Hepatic failure, n (%)

75 (2)

80 (3)

0.033

77 (2)

0.114

56 (3)

0.003

 Lymphoma, n (%)

34 (1)

30 (1)

0.606

31 (1)

0.638

24 (1)

0.104

 Metastatic cancer, (%)

138 (3)

114 (4)

0.489

119 (4)

0.496

1806(96)

0.287

 Leukemia, n (%)

69 (2)

59 (2)

0.521

73 (2)

0.089

28 (1)

0.744

 Immunosuppression, n (%)

213 (5)

192 (6)

0.068

200 (6)

0.072

103 (5)

0.496

 Cirrhosis, n (%)

123 (3)

107 (3)

0.292

113 (3)

0.253

58 (3)

0.756

Outcome

       

 ICU mortality, n (%)

500 (12)

471 (15)

 < 0.001

467 (14)

0.005

268 (14)

0.008

 Hospital mortality, n (%)

808 (19)

688 (22)

0.008

724 (22)

0.005

398 (21)

0.059

 Length of ICU stay, median (IQR)

53 (29, 101)

55 (29, 113)

0.172

53 (28, 105)

0.95

54 (28, 100.75)

0.736

  1. Continuous data are presented as median (interquartile range), whereas categorical data are presented as frequency (percentage)
  2. *p values compare the development cohort to each of the three validation cohorts using Wilcoxon Mann–Whitney test or exact Fisher test depending on whether the variable is continuous or categorical